Loading…

S180: RESULTS OF A PHASE 3 TRIAL OF AN ORAL CXCR4 ANTAGONIST, MAVORIXAFOR, FOR TREATMENT OF PATIENTS WITH WHIM SYNDROME

Saved in:

Bibliographic Details
Published in:	HemaSphere 2023-08, Vol.7 (S3), p.e684700a-n/a
Main Authors:	Badolato, Raffaele, Donadieu, Jean
Format:	Article
Language:	English
Subjects:	Oral Sessions
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!